Key Players
- Almac Group
- Astellas Pharma Inc
- BlackRock
- Asymchem Laboratories
- Aurisco Pharmaceutical
- Aurobindo Pharma
- Authorization Holders
- Bayer
- Boehringer Ingelheim
- CDMO Companies
- Cardinal Health
- Catalent Inc
- Catalent UK
- Celltrion Pharm
- Cencora Inc
- Chong Kun Dang
- Cipla Ltd
- Commercial Access Companies
- Complex API
- Crystal Pharmaceutical (Suzhou) Co. Ltd
- Daewoong Pharmaceutical
- Daiichi Sankyo Company
- December 2025
- Delpharm
- Divi’s Laboratories Ltd
- Dong-A ST
- Dr. Reddy’s Laboratories
- Eisai Co. Ltd
- EuroAPI
- European Union
- Evonik Health Care
- Fareva
- GSK plc
- Hanmi Pharm. Co. Ltd
- Hetero Drugs
- Idorsia Pharmaceuticals Deutschland GmbH
- Idorsia Pharmaceuticals Ltd
- Idorsia Pharmaceuticals US Inc
- Ipsen S.A
- Janssen Biotech Inc
- Laurus Labs
- MSN Laboratories
- McKesson Corporation
- Merck KGaA
- Mitsubishi Tanabe Pharma Corporation
- Otsuka Pharmaceutical Co. Ltd
- Porton Pharma Solutions
- Quotient Sciences
- Recipharm AB
- Rentschler Biopharma SE
- Samsung Biologics
- L'Oréal
- Seqens
- Servier
- Shionogi & Co. Ltd
- Takeda Pharmaceutical Company Limited
- Thermo Fisher Scientific Inc.
- Vetter Pharma
- Walgreens Specialty Pharmacy
- WuXi STA
- Yuhan Corporation
- Zhejiang Huahai Pharmaceutical
- Zhejiang Jiuzhou Pharmaceutical
